Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer



Meet Our Executive Guest Editor free to download

Volume:20   Issue: 3
Pp: 167-167
H. Konig
DOI: 10.2174/156800962003200207113653



Cancer Cell-derived Secretory Factors in Breast Cancer-associated Lung Metastasis: Their Mechanism and Future Prospects open access plus

Volume:20   Issue: 3
Pp: 168-186
Tabinda Urooj*, Bushra Wasim, Shamim Mushtaq, Syed Nudrat Nawaid Shah and Muzna Shah
DOI: 10.2174/1568009620666191220151856




The Potential Use of Anticancer Peptides (ACPs) in the Treatment of Hepatocellular Carcinoma

Volume:20   Issue: 3
Pp: 187-196
Chu Xin Ng and Sau Har Lee*
DOI: 10.2174/1568009619666191111141032



PPARγ Agonists in Combination Cancer Therapies

Volume:20   Issue: 3
Pp: 197-215
Piotr Mrowka and Eliza Glodkowska-Mrowka*
DOI: 10.2174/1568009619666191209102015




Effects of Intermittent Hypoxia on Expression of Glucose Metabolism Genes in MCF7 Breast Cancer Cell Line

Volume:20   Issue: 3
Pp: 216-222
Yazun Jarrar, Malek Zihlif*, Abdel Qader Al Bawab and Ahmad Sharab
DOI: 10.2174/1568009619666191116095847




Use of Small-molecule Inhibitory Compound of PERK-dependent Signaling Pathway as a Promising Target-based Therapy for Colorectal Cancer

Volume:20   Issue: 3
Pp: 223-238
Wioletta Rozpędek, Dariusz Pytel, Adam Wawrzynkiewicz, Natalia Siwecka, Adam Dziki, Łukasz Dziki, J. Alan Diehl and Ireneusz Majsterek*
DOI: 10.2174/1568009620666200106114826